Transferrin Receptor in Lung Cancer
Author Information
Author(s): A Dowlati, M Loo, T Bury, G Fillet, Y Beguin
Primary Institution: University of Liege, School of Medicine, Liege, Belgium
Hypothesis
Can measuring soluble and cell-associated transferrin receptor (TfR) levels in lung cancer patients provide diagnostic value compared to patients with chronic obstructive pulmonary disease (COPD)?
Conclusion
Cell-associated TfR levels in bronchoalveolar lavage fluid may assist in differentiating lung cancer from pneumonia.
Supporting Evidence
- Cell-associated TfR levels were significantly higher in BAL fluid of NSCLC patients than in COPD patients (P = 0.01).
- A combination of BAL supernatant NSE and cell-associated TfR detected lung cancer with a sensitivity of 91%.
- The calculated number of TfR molecules per cell in BAL correlated positively with the percentage of macrophages in BAL (P < 0.0001).
- No correlation existed between BAL cell-associated TfR and tumour size, nodal status, or presence of metastases.
Takeaway
Doctors can check a special protein in the lungs to help tell if someone has lung cancer or just a lung infection.
Methodology
The study measured soluble and cell-associated TfR in serum and bronchoalveolar lavage fluid from lung cancer and COPD patients using ELISA.
Limitations
The study had a limited number of patients, which may affect the generalizability of the results.
Participant Demographics
32 lung cancer patients (23 NSCLC, 9 SCLC) and 22 COPD patients, mostly heavy smokers, with a mean age of 66 for lung cancer and 62 for COPD.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website